Wim H van Harten Selected Research

Wim H van Harten Research Topics

16	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2012
9	Neoplasms (Cancer) 12/2020 - 08/2010
4	Fatigue 07/2018 - 12/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2021 - 08/2014
2	Melanoma (Melanoma, Malignant) 11/2018 - 09/2018
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 12/2010
2	Triple Negative Breast Neoplasms 06/2016 - 08/2015
1	Nausea 12/2022
1	Vomiting 12/2022
1	Prostatic Neoplasms (Prostate Cancer) 10/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022
1	Apnea 05/2021
1	Obstructive Sleep Apnea 05/2021
1	Cardiotoxicity 01/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2019
1	Wounds and Injuries (Trauma) 12/2017
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 03/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2011

2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2016
1	Cell-Free Nucleic AcidsIBA 03/2022
1	TabletsIBA 05/2021
1	AnthracyclinesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	cyclic adenosine-5'-trimetaphosphate (ATMP)IBA 11/2018
1	IpilimumabIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 12/2017
1	Carrier Proteins (Binding Protein)IBA 06/2016
1	Hormones (Hormone)IBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016

14	Drug Therapy (Chemotherapy) 12/2022 - 08/2010
9	Adjuvant Chemotherapy 01/2022 - 12/2010
6	Radiotherapy 05/2021 - 08/2010
4	Therapeutics 11/2018 - 07/2013
3	Neoadjuvant Therapy 04/2017 - 01/2016
2	Segmental Mastectomy (Lumpectomy) 05/2021 - 08/2014
1	Aftercare (After-Treatment) 12/2022
1	Prostatectomy (Retropubic Prostatectomy) 10/2022
1	Continuous Positive Airway Pressure 05/2021
1	Patient Readmission 01/2021
1	Laryngectomy 01/2021
1	Hyperthermic Intraperitoneal Chemotherapy 10/2019
1	Cytoreduction Surgical Procedures 10/2019
1	Continuity of Patient Care 07/2019
1	Ligation 06/2016
1	Adjuvant Radiotherapy 08/2014
1	Stem Cell Transplantation 06/2012